PhaseV scores $50M for AI clinical trial platform – RamaOnHealthcare

PhaseV scores $50M for AI clinical trial platform – RamaOnHealthcare

The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical

PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients

BOSTON, May 13, 2025 /PRNewswire/ — PhaseV, a leader in AI/ML-driven clinical development, today announced the completion of a $50 million Series A funding round. Co-led by Accel and Insight Partners and with participation of existing investors Viola Ventures, EXOR and LionBird, the round brings the company’s total funding to date to $65 million. “The pharma industry is at a critical crossroads, as traditional approaches to designing and executi…

PhaseV Closes $50M to Advance AI Clinical Development

What You Should Know:  – PhaseV, a company at the forefront of applying artificial intelligence (AI) and machine learning (ML) to clinical development raies $50M in Series A funding round co-led by Accel and Insight Partners, with participation from existing investors Viola Ventures, EXOR, and LionBird. This round brings PhaseV’s total funding to date to $65M. – The new capital is earmarked to fuel PhaseV’s mission to support pharmaceutical comp…